Cardiac-specific ablation of glutaredoxin 3 leads to cardiac hypertrophy and heart failure.
Donelson J, Wang Q, Monroe TO, Jiang X, Zhou J, Yu H, Mo Q, Sun Q, Marini JC, Wang X, Nakata PA, Hirschi KD, Wang J, Rodney GG, Wehrens XHT, Cheng N.
Donelson J, et al. Among authors: yu h.
Physiol Rep. 2019 Apr;7(8):e14071. doi: 10.14814/phy2.14071.
Physiol Rep. 2019.
PMID: 31033205
Free PMC article.